Clinical Trial Update: Mifepristone in Children With Refractory Cushing's Disease [Phase 3]

View source ↗

Summary

The Phase 3 trial of mifepristone in children with refractory Cushing's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Cushing's Disease | Phase 3 | Status: WITHDRAWN